Cellcom Israel CEL
-
Cellcom Israel Hurting on Prevalent Price Erosion
Cellcom Israel CEL reported weak first-quarter earnings and gave investors a bleak second-quarter outlook that was in line with our expectations …
-
Premarket gainers: [[GRPN]] +24%. [[ACHN]] +7%. [[DKS]] +6%. [[ZNGA]] + 6%. Losers: [[SUMR]] -31%. [[AVP]] -13%. [[TEF]] -8%. [[NBG]] -6%. [[ CEL ]] -6%.
Premarket gainers: GRPN +24% . ACHN +7% . DKS +6% . ZNGA + 6%. Losers: SUMR -31% . AVP -13% . TEF -8% . NBG -6% . CEL -6% . Post your comment!
-
Cellcom Israel ( CEL ): Q1 EPS of NIS1.74 beats by NIS0.02. Revenue of NIS1.58B (-0.1% Y/Y) beats by NIS130M. (PR)
Cellcom Israel ( CEL ): Q1 EPS of NIS1.74 beats by NIS0.02 . Revenue of NIS1.58B (-0.1% Y/Y) beats by NIS130M . ( PR ) Post your comment!
-
Cellcom Israel , Ltd. CEL Q1 2012 Earnings Call Transcript
… you for standing by. Welcome to the Cellcom Israel Ltd First Quarter 2012 results Conference ..... you to the conference call and thanks Cellcom Israel 's management for hosting this call ..... followed by Mr. Heen who will review Cellcom Israel 's financial performance in further …
-
Cel -Sci Shares Still Undervalued: How Does This Make Sense?
… shares have been quietly setting higher lows since the start of the year, when one does the math Cel -Sci ( CVM ) still looks undervalued. Consider that CEL -SCI has raised around $200 million to forward Multikine research and trials. Over $70 million …
-
New Morningstar Analyst Report - Partner Communications Company, Ltd.
… future. When Partner entered Israel's telecom industry in 1998, the wireless market was split between two providers, Cellcom CEL and Pelephone. Partner quickly minted its reputation for superior network quality and strong customer service, earning the …
-
Technical And Fundamental Breakout In Play For CEL -SCI Corporation
… Michael Morhamus : Shares of Virginia based biotechnology company, CEL -SCI Corporation (AMEX: CVM ) appear to be technically breaking ..... be fuelling the price rise. Primarily focused on Oncology, CEL -SCI seems to have most of its value is locked in Multikine …
-
Cel -Sci Offers Huge Potential Gains With Revolutionary Immunotherapy Anti-Cancer Drug
By Brian L. Wilson : Cel -Sci ( CVM ) is working in conjunction with Teva Pharmaceuticals ( TEVA ) in the development of Multikine, a revolutionary drug …
-
New Morningstar Analyst Report - Cellcom Israel , Ltd.
… financial status, but Cellcom acknowledges in its annual report that it has built without a permit in some locations. Cellcom Israel Ltd, founded in 1994, is Israel's largest telecommunication provider by customer base. While high profit margins and …
-
Cellcom Israel Reports Lower-Than-Expected Fourth-Quarter and Full-Year Results
We are lowering our fair value estimate for Cellcom Israel CEL to $10 per ADR from $26. The decline is due to poor performance in the fourth quarter and full year 2011, a deteriorating competitive …